REFERENCES

References

1. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits; a preliminary report. BMJ. 1954;1(4877):14511455. Crossref, MedlineGoogle Scholar
2. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18(4):858867. Crossref, MedlineGoogle Scholar
3. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160164. Crossref, MedlineGoogle Scholar
4. Michels KB, Willett WC, Graubard BI, et al. A longitudinal study of infant feeding and obesity throughout life course. Int J Obes (Lond). 2007;31(7):10781085. Crossref, MedlineGoogle Scholar
5. Hu FB, Satija A, Rimm EB, et al. Diet assessment methods in the Nurses' Health Studies and contribution to evidence-based nutritional policies and guidelines. Am J Public Health. 2016;106(9):15671572. LinkGoogle Scholar
6. Wolf AM, Hunter D, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991999. Crossref, MedlineGoogle Scholar
7. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC. Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol. 1990;131(6):10681071. Crossref, MedlineGoogle Scholar
8. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123(5):894900. Crossref, MedlineGoogle Scholar
9. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1(6):466473. Crossref, MedlineGoogle Scholar
10. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11):10161019. Crossref, MedlineGoogle Scholar
11. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem. 1989;35(12):23132316. MedlineGoogle Scholar
12. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97(14):10841087. Crossref, MedlineGoogle Scholar
13. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80(12):19431949. Crossref, MedlineGoogle Scholar
14. Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study. Mod Pathol. 2011;24(7):924931. Crossref, MedlineGoogle Scholar
15. Collins LC, Marotti JD, Baer HJ, Tamimi RM. Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst. 2008;100(3):218221. Crossref, MedlineGoogle Scholar
16. Holmes MD, Chen WY, Schnitt SJ, et al. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011;130(2):657662. Crossref, MedlineGoogle Scholar
17. Hu R, Dawood S, Holmes MD, et al. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011;17(7):18671874. Crossref, MedlineGoogle Scholar
18. Liu Y, Tamimi RM, Collins LC, et al. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study. Breast Cancer Res Treat. 2011;129(1):175184. Crossref, MedlineGoogle Scholar
19. Santagata S, Hu R, Lin NU, et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci USA. 2011;108(45):1837818383. Crossref, MedlineGoogle Scholar
20. Tamimi RM, Baer HJ, Marotti J, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008;10(4):R67. Crossref, MedlineGoogle Scholar
21. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397411. Crossref, MedlineGoogle Scholar
22. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst. 2010;102(6):365367. Crossref, MedlineGoogle Scholar
23. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21):16221629. Crossref, MedlineGoogle Scholar
24. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001;154:163169. MedlineGoogle Scholar
25. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep. 2001;3(4):314321. Crossref, MedlineGoogle Scholar
26. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005;14(11 pt 1):26412647. Crossref, MedlineGoogle Scholar
27. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):11781187. Crossref, MedlineGoogle Scholar
28. Liao X, Zucker DM, Li Y, Spiegelman D. Survival analysis with error-prone time-varying covariates: a risk set calibration approach. Biometrics. 2011;67(1):5058. Crossref, MedlineGoogle Scholar
29. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):24792486. Crossref, MedlineGoogle Scholar
30. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9):14671472. Crossref, MedlineGoogle Scholar
31. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649658. Crossref, MedlineGoogle Scholar
32. Townsend MK, Clish CB, Kraft P, et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem. 2013;59(11):16571667. Crossref, MedlineGoogle Scholar
33. Mayers JR, Wu C, Clish CB, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014;20(10):11931198. Crossref, MedlineGoogle Scholar
34. Colditz GA, Philpott SE, Hankinson SE. The impact of the Nurses’ Health Study on population health: prevention, translation, and control. Am J Public Health. 2016;106(9):15401545. LinkGoogle Scholar

Related

No related items

TOOLS

SHARE

ARTICLE CITATION

Ying Bao, MD, ScD, Monica L. Bertoia, PhD, MPH, Elizabeth B. Lenart, PhD, Meir J. Stampfer, MD, DrPH, Walter C. Willett, MD, DrPH, Frank E. Speizer, MD, and Jorge E. Chavarro, MD, ScDYing Bao, Meir J. Stampfer, and Frank E. Speizer are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. Monica L. Bertoia, Elizabeth B. Lenart, Walter C. Willett, and Jorge E. Chavarro are with the Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA. “Origin, Methods, and Evolution of the Three Nurses’ Health Studies”, American Journal of Public Health 106, no. 9 (September 1, 2016): pp. 1573-1581.

https://doi.org/10.2105/AJPH.2016.303338

PMID: 27459450